KR920009783A - 인단 및 퀴놀린 유도체 - Google Patents

인단 및 퀴놀린 유도체 Download PDF

Info

Publication number
KR920009783A
KR920009783A KR1019910021074A KR910021074A KR920009783A KR 920009783 A KR920009783 A KR 920009783A KR 1019910021074 A KR1019910021074 A KR 1019910021074A KR 910021074 A KR910021074 A KR 910021074A KR 920009783 A KR920009783 A KR 920009783A
Authority
KR
South Korea
Prior art keywords
alkyl
cyano
dimethyl
trans
hydroxy
Prior art date
Application number
KR1019910021074A
Other languages
English (en)
Inventor
앳월 카네일
Original Assignee
니콜라스 피. 말라테스티닉
이이. 아르. 스퀴브 앤드 산즈. 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 니콜라스 피. 말라테스티닉, 이이. 아르. 스퀴브 앤드 산즈. 인크. filed Critical 니콜라스 피. 말라테스티닉
Publication of KR920009783A publication Critical patent/KR920009783A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)

Abstract

내용 없음.

Description

인단 및 퀴놀린 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 하기일반식(Ⅰ)의 화합물.
    상기식 중에서, X는 O, S 또는 NCN일 수 있으며, 단, X가 O또는 S이면, A는 단일 결합이고, 또는 x가 NCN이면, A는 단일 결합, －CH2－, －NR9－ (여기서 R9는 수소 또는 탄소수 1내지 4의 저급 알킬임), －S－, －SO－ 또는 －SO2이고, Y는 －NR8, －O－, －S－ 또는이고, R1은 아릴, 아릴아킬, 헤테로시클로 또는 (헤테로시클로)알킬이고, R2는 수소, 히드록시,이고, R3및R4는 각각 독립적으로 수소, 알킬 또는 아릴알킬이거나, 또는 R3및 R4는 그들이 부착된 탄소 원자와 함께 5－ 내지 7－원 카르보시클릭 고리를 형성하고, R5는 H, 알킬, 할로알킬, 알케닐, 알키닐, 시클로알킬, 아릴알킬, 시클로알킬알킬, －CN, －NO2, －COR, －COOR, －CONHR, －CONR2, －CF3, S－ 알킬, －SO 알킬, －SO2알킬,(O－알킬)2,
    할로겐, OCF3, OCH2CH3로 부터 선택되고, 여기서 각각의 R은 수소, 알킬, 아릴, 아릴알킬, 시크로알킬, (시클로알킬)알킬 또는 할로알킬일 수 있으며, R6은 H, 알킬 할로, OH, O－알킬, 아미노 및 치환된 아미노, O－알킬, －OCO 알킬, －OCONR 알킬, －NRCO 알킬 및 NRCOO알킬, NRCONR2로 부터 선택되고, 여기서 각각의 R은 수소, 알킬, 아릴, 아릴알킬, 시클로알킬, (시클로알킬)알킬 또는 할로알킬일 수 있으며, R7및 R8은 각각 독립적으로 수소, 알킬, 아릴알킬로부터 선택되거나, 또는 R1및 R8, 또는 R1및 R7또는 R7및 R8은함께 5 내지 7－원고리를 형성하여, 이들은 이러한 5－ 내지 7－ 원 고리의 2탄소 원자에 융합된 아릴기를 더 포함할 수도 있으며, n은 1, 2 또는 3이고, R10은 수소, 히드록시, 알킬 또는 O－알킬이다.
  2. 제1항에 있어서, A는 단일 결합 또는 CH2이고, R1은 아릴 또는 아릴메틸이고, R2는 H또는 트랜스 －OH이고, R3및 R4는 각각 메틸이고, R5는 H이고, R6은 CN 또는 NO2이고, R7은 H이고, X는 O, S 또는 NCN이고, Y는 NR8또는 CH2이고, R8은 H인 화합물.
  3. 제1항에 있어서, A는 단일 결합이고, R1은 아페닐 또는 페닐메틸이고, R2는 트랜스 －OH이고, R3및 R4는 각각 메틸이고, R5는 H이고, R6은 CN 또는 NO2이고, R7은 H이고, X는 O 또는 NCN이고, Y는 NR8이고, R8은 H인 화합물.
  4. 제1항에 있어서, (트랜스)－N″－시아노－N－(2－히드록시－3, 3－디메틸－6－니트로－1－인다닐)－N′－페닐구아니딘인 화합물.
  5. 제1항에 있어서, (트랜스)－N－(2－히드록시－3, 3－디메틸－6－니트로－1－인다닐)－N′－페닐우레아인 화합물.
  6. 제1항에 있어서, (트랜스)－N－(2－히드록시－3, 3－디메틸－6－니트로－1－인다닐)－N′－(페닐메틸)우레아인 화합물.
  7. 제1항에 있어서, (트랜스)－N－(6－브로모, 1, 2, 3, 4－테트라히드로－3－히드록시－2, 2－디메틸－4－퀴놀리닐)－N″－시아노－N′－페닐구아니딘인 화합물.
  8. 제1항에 있어서, (트랜스)－N－(6－시아노, 1, 2, 3, 4－테트라히드로－3－히드록시－2, 2－디메틸－4－퀴놀리닐)－N″－시아노－N′－페닐구아니딘인 화합물.
  9. 제1항에 있어서, N－(6－시아노－3, 3－디메틸－1－인다닐)－N′－페닐 우레아인 화합물.
  10. 제1항에 있어서, N－(6－시아노－3, 3－디메틸－1－인다닐)－N′－페닐 우레아인 화합물.
  11. 제1항에 있어서, N″－시아노－N′－(6－시아노－3, 3－디메틸－1－인다닐)－N′－페구아니딘인 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910021074A 1990-11-26 1991-11-25 인단 및 퀴놀린 유도체 KR920009783A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61835790A 1990-11-26 1990-11-26
US618,357 1990-11-26

Publications (1)

Publication Number Publication Date
KR920009783A true KR920009783A (ko) 1992-06-25

Family

ID=24477368

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910021074A KR920009783A (ko) 1990-11-26 1991-11-25 인단 및 퀴놀린 유도체

Country Status (17)

Country Link
US (1) US5401848A (ko)
EP (1) EP0488616A1 (ko)
JP (1) JPH04352753A (ko)
KR (1) KR920009783A (ko)
CN (1) CN1061961A (ko)
AU (1) AU637535B2 (ko)
CA (1) CA2054637A1 (ko)
FI (1) FI915530A (ko)
HU (1) HU209470B (ko)
IE (1) IE913867A1 (ko)
IL (1) IL99902A0 (ko)
NO (1) NO176095C (ko)
NZ (1) NZ240615A (ko)
PL (1) PL166983B1 (ko)
PT (1) PT99605A (ko)
RU (1) RU2058980C1 (ko)
ZA (1) ZA918539B (ko)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU651105B2 (en) * 1990-06-18 1994-07-14 E.R. Squibb & Sons, Inc. Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
US5374643A (en) * 1992-09-11 1994-12-20 E. R. Squibb & Sons, Inc. Aryl urea (thiourea) and cyanoguanidine derivatives
US5453421A (en) * 1992-09-11 1995-09-26 E. R. Squibb & Sons, Inc. Aryl and heterocyclic substituted propenamide derivatives
US5514690A (en) * 1992-11-17 1996-05-07 E. R. Squibb & Sons, Inc. Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
EP0764639A4 (en) * 1994-06-09 1997-10-01 Ss Pharmaceutical Co 4-CHINOLINONE DERIVATIVE OR ITS SALT
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
WO1997025983A1 (en) * 1996-01-22 1997-07-24 Eli Lilly And Company Indane derivatives for antipsychotic compositions
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
AU4997199A (en) * 1998-07-16 2000-02-07 Axys Pharmaceuticals, Inc. Process for the synthesis of benzopyran derivatives
GT199900147A (es) 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
US6147090A (en) * 1998-09-17 2000-11-14 Pfizer Inc. 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
US6147089A (en) * 1998-09-17 2000-11-14 Pfizer Inc. Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
AU781365B2 (en) * 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
US6566380B2 (en) * 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
RU2372344C2 (ru) 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
BRPI0515830A (pt) 2004-12-21 2008-08-05 F Hoffmann La Roche derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central
CA2591793A1 (en) 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101119965B (zh) 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
ES2306275T3 (es) 2004-12-21 2008-11-01 F. Hoffmann-La Roche Ag Derivados de cromano y sus usos como ligandos dde receptores 5-ht.
AU2005318598B2 (en) 2004-12-21 2010-08-26 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof as 5-HT antagonists
CN100381398C (zh) * 2005-07-29 2008-04-16 南京理工大学 AlN－Si3N4－SiC陶瓷材料的制备方法
DE602006020351D1 (en) 2005-11-03 2011-04-07 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
JP2009541249A (ja) 2006-06-20 2009-11-26 エフ．ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
CN107540566A (zh) * 2017-08-28 2018-01-05 江苏绿叶农化有限公司 一种炔苯酰草胺的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126367B1 (en) * 1983-05-18 1994-10-12 Beecham Group Plc Chroman and chromene derivatives
GB8414987D0 (en) * 1984-06-12 1984-07-18 Beecham Group Plc Active compounds
ATE56007T1 (de) * 1984-06-22 1990-09-15 Beecham Group Plc Wirksame benzopyranverbindungen.
DE3583780D1 (de) * 1984-08-31 1991-09-19 Otsuka Pharma Co Ltd 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK691488A (da) * 1987-12-14 1989-06-15 Beecham Group Plc Hidtil ukendte forbindelser
GB8730052D0 (en) * 1987-12-23 1988-02-03 Beecham Group Plc Novel compounds
US4988723A (en) * 1988-06-02 1991-01-29 Fujisawa Pharmaceutical Co., Ltd. Benzopyran derivatives and their use as anti-hypertensives
ES2088895T3 (es) * 1988-09-16 1996-10-01 Beecham Group Plc Derivados de benzopirano con actividad antihipertensora.
DE69029668T2 (de) * 1989-03-08 1997-08-07 Merck Sharp & Dohme Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives

Also Published As

Publication number Publication date
NO914602L (no) 1992-05-27
EP0488616A1 (en) 1992-06-03
RU2058980C1 (ru) 1996-04-27
HU209470B (en) 1994-06-28
ZA918539B (en) 1992-08-26
PL292536A1 (en) 1992-09-21
AU637535B2 (en) 1993-05-27
PT99605A (pt) 1992-10-30
IE913867A1 (en) 1992-06-03
CA2054637A1 (en) 1992-05-27
NZ240615A (en) 1994-05-26
NO176095C (no) 1995-02-01
NO914602D0 (no) 1991-11-25
HUT60467A (en) 1992-09-28
CN1061961A (zh) 1992-06-17
PL166983B1 (pl) 1995-07-31
AU8804091A (en) 1992-05-28
JPH04352753A (ja) 1992-12-07
US5401848A (en) 1995-03-28
NO176095B (no) 1994-10-24
HU913664D0 (en) 1992-02-28
IL99902A0 (en) 1992-08-18
FI915530A (fi) 1992-05-27
FI915530A0 (fi) 1991-11-25

Similar Documents

Publication Publication Date Title
KR920009783A (ko) 인단 및 퀴놀린 유도체
KR940005633A (ko) 약제학적으로 유용한 항경련제 설파메이트의 이미데이트 유도체
BR0010366A (pt) Composto, composição farmacêutica, método de preparar um composto, e, composto para uso em terapia
KR900018064A (ko) 피라닐 시아노구아니딘 유도체
KR910006241A (ko) 피리미딘-4,6-디카복실산 디아미드, 이의 제조방법, 이의 용도 및 이들 화합물을 기초로 하는 약제
DK71780A (da) Fremgangsmaade til fremstilling af difenylhydantoinderivater
SE8406302L (sv) Nya aminoguanidinderivat och ett forfarande for deras framstellning
ES532337A0 (es) Procedimiento para la preparacion de 6-aril-3 (2h)piridazinonas
FI862909A (fi) Foerfarande foer framstaellning av nya indolkarboxamidderivat och deras salter.
DK420682A (da) Fremgangsmaade til fremstilling af triazoloquinazoloner eller salte deraf
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
NO912298D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksanderivater.
SE8006953L (sv) Heterocykliska foreningar
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
SE8303913D0 (sv) Heterocykliska foreningar
ES509536A0 (es) "procedimiento para preparar nuevos derivados de triazoloquinazolinona".
ES553437A0 (es) Un procedimiento para preparar nuevos derivados de (4.2.0) biciclooctano
ES503771A0 (es) Un procedimiento para la preparacion de derivados de propa- nolamina
SE425395B (sv) Forfarande for framstellning av fenyl- eller bensylfosfonatestrar
DE3884319D1 (de) Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
EA199800083A1 (ru) Производные 1,3-оксазин-4-она в качестве гербицидов
DE3689321D1 (de) Hydroxyalkoxy-4-phenylpropylindolderivate, ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammensetzungen die sie enthalten.
ES538155A0 (es) Procedimiento para la obtencion de un derivado de arganofosfato
ES500108A0 (es) Procedimiento para preparar nuevas benzotiopirano (2,3-c)pi-ridinas
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid